Thought Leadership: Healthcare

Is Inflation Cutting Health from Shopper’s Budgets?

As COVID-19 concerns decrease, a separate issue is on the rise — and having its own (unexpected) impact on healthcare. Inflation.

• Read more about Is Inflation Cutting Health from Shopper’s Budgets?

EPA REGULATIONS AND COMPLIANCE IS CHANGING IN JULY

Managing hazardous pharmaceutical waste compliance is critical to your healthcare facility, but so is making sure staff have time to focus on their patients. With already complex federal and state regulations constantly changing, it might be difficult for your healthcare facility to balance those duties. You can’t afford to sacrifice either one, so what’s the best course of action?

• Read more about EPA REGULATIONS AND COMPLIANCE IS CHANGING IN JULY

Medical Recalls: Not “If” but “When”

Whether it’s for devices, supplies, or pharmaceuticals, eventually your hospital system will be impacted by a recall. The best way to prepare is to make certain your health system knows as much about those events as possible. And immediately. Any delay could lead to patient or staff injury. Or worse. Speed and accuracy — in gathering information and in mitigating risk — is critical.

• Read more about Medical Recalls: Not “If” but “When”

DSCSA 2023 — What You Need to Know About Staying Compliant

As we approach the final stage of our industry’s 10-year implementation of the Drug Supply Chain Security Act (DSCSA), Inmar Intelligence remains committed to keeping the healthcare community informed — so you can achieve DSCSA compliance. 

• Read more about DSCSA 2023 — What You Need to Know About Staying Compliant

Community Makes Consumer Drug Take-Back Day a Success

Did you participate in National Prescription Drug Take-Back Day? We hope so! Inmar Intelligence hosted our third Consumer Drug Take-Back event in conjunction with the Winston-Salem Police Department on October 23rd. These Take-Back days provide a convenient and safe way to dispose of unused medications and a chance to help make our communities safer. Every participant is helping us bring awareness to the problem of surplus prescription drugs in our communities.

• Read more about Community Makes Consumer Drug Take-Back Day a Success

Consumer Drug Take-Back Milestone — Half A Million Pounds Collected!

Half a million pounds. It sounds like a lot, but how much is it? Half a million pounds is equivalent to two and a half blue whales, a 2,500 square foot home or a locomotive engine. That’s how much unwanted medication we’ve collected through the placement of 4,000 kiosks with the Consumer Drug Take-Back program.

• Read more about Consumer Drug Take-Back Milestone — Half A Million Pounds Collected!

Consumer Drug Take-Back — It's Not Only A Public Health Issue, It's Personal

This year, overdose deaths increased 30% in the US, reaching the highest rate in our country’s history. That means, on average, over 260 Americans die every day from a drug overdose, according to the CDC. This persistent (and increasing) problem demands new solutions. Inmar surveyed 1,000 adults across the US to understand how they’re personally impacted by prescription drug misuse, and to gauge their awareness of proper disposal options.

• Read more about Consumer Drug Take-Back — It's Not Only A Public Health Issue, It's Personal

The drug supply chain never stops. Neither do we.

At Inmar, we’re intimately involved in the drug supply chain; from delivering data and insights at a drug’s market entry to facilitating its final disposition. We’ve set out to simplify the complex -- throughout the drug journey -- to drive greater efficiency, reduce waste, ensure compliance and support sustainability.

• Read more about The drug supply chain never stops. Neither do we.

More time for patients is the sign of an Inmar client

For pharmacy managers operating in today’s rapidly evolving healthcare space, it seems there are more questions than answers.

• Read more about More time for patients is the sign of an Inmar client